ReachMD

Be part of the knowledge.™

Medical Industry Feature

Medical Industry Feature highlights topics brought to you by makers of products and services in the medical industry.

339

LikeLikedUnlike

Episodes 1-15 of 165

Taking a Unique Approach to Anti-AChR Antibody Positive gMG Treatment
Live Broadcast
Taking a Unique Approach to Anti-AChR Antibody Positive gMG Treatment
October 13, 2023
03:00 PM - 03:45 PM EDT
- Bennett H. Myers, MD
  Peer
Learn more
Taking a Unique Approach to Anti-AChR Antibody Positive gMG Treatment
Live Broadcast
Taking a Unique Approach to Anti-AChR Antibody Positive gMG Treatment
October 13, 2023
06:00 PM - 06:45 PM EDT
- Bennett H. Myers, MD
  Peer
Learn more
Examining Unmet Needs in Gastric and GEJ Cancer Care and the Role of Emergining Personalized Medicine
Medical Industry Feature
Examining Unmet Needs in Gastric and GEJ Cancer Care and the Role of Emergining Personalized Medicine
- Nataliya Uboha, MD, PhD
  Peer
Pathways to Evolving Personalized Medicine in Gastric and GEJ Cancer: An Overview of Current Established and Emerging Biomarkers
Medical Industry Feature
Pathways to Evolving Personalized Medicine in Gastric and GEJ Cancer: An Overview of Current Established and Emerging Biomarkers
- Charles Turck, PharmD, BCPS, BCCCP
  Peer
- Kristina Matkowskyj, MD, PhD
  Peer
- Nataliya Uboha, MD, PhD
  Peer
Experts Discuss What the TITAN Trial Means for Managing Patients With mCSPC
Medical Industry Feature
Experts Discuss What the TITAN Trial Means for Managing Patients With mCSPC
- Joelle Hamilton, MD
  Peer
- Michael Fabrizio, MD, FACS
  Peer
- Mahdi Taha, DO
  Peer
Early Intervention Strategies for Patients With T2D & ASCVD Risk
Medical Industry Feature
Early Intervention Strategies for Patients With T2D & ASCVD Risk
- Joshua Stolker, MD
  Peer
Improving Patient Care in SCLC: A Proactive Strategy from Dr. Kalmadi
Medical Industry Feature
Improving Patient Care in SCLC: A Proactive Strategy from Dr. Kalmadi
- Sujith Kalmadi, MD
  Peer
ASCVD Risk Reduction in Patients With T2D
Medical Industry Feature
ASCVD Risk Reduction in Patients With T2D
- Joshua Stolker, MD
  Peer
Improving Patient Care in SCLC: A Proactive Strategy from Dr. Porter
Medical Industry Feature
Improving Patient Care in SCLC: A Proactive Strategy from Dr. Porter
- Jason Porter, MD
  Peer
Investigating DLL3-Targeted Immunotherapy: The Potential of T Cells to Fight SCLC
Medical Industry Feature
Investigating DLL3-Targeted Immunotherapy: The Potential of T Cells to Fight SCLC
- Jennifer Caudle, DO
  Peer
- Taofeek K. Owonikoko, MD, PhD
  Peer
The Importance of the Patient Experience During the Treatment of Spinal Muscular Atrophy
Medical Industry Feature
The Importance of the Patient Experience During the Treatment of Spinal Muscular Atrophy
- Charles Turck, PharmD, BCPS, BCCCP
  Peer
- Nassim Rad, MD
  Peer
- Kevin Koo, MD
  Peer
Addressing Hesitancy on Biosimilars: From Development to Clinical Practice
Medical Industry Feature
Addressing Hesitancy on Biosimilars: From Development to Clinical Practice
- Charles Turck, PharmD, BCPS, BCCCP
  Peer
- Jerome Goldschmidt, MD
  Peer
Tailored to Fit: Precision Medicine in Metastatic CRC
Medical Industry Feature
Tailored to Fit: Precision Medicine in Metastatic CRC
- Charles Turck, PharmD, BCPS, BCCCP
  Peer
- Kristen Ciombor, MD
  Peer
- Mark Lewis, MD
  Peer
Navigating mCRC: A Closer Look at Biomarker Testing
Medical Industry Feature
Navigating mCRC: A Closer Look at Biomarker Testing
- Charles Turck, PharmD, BCPS, BCCCP
  Peer
- Kristen Ciombor, MD
  Peer
From Monoamines to Neurocircuits: Our Evolving Understanding of Depression
Medical Industry Feature
From Monoamines to Neurocircuits: Our Evolving Understanding of Depression
- Charles Turck, PharmD, BCPS, BCCCP
  Peer
- Joseph F. Goldberg, MD
  Peer

Program Chapters

Segment Chapters

Playlist:

Recommended